Literature DB >> 29344195

Collagen triple helix repeat containing 1 promotes tumor angiogenesis in gastrointestinal stromal tumors.

Seng Wang Fu1, Hai Ying Chen1, Xiao Lu Lin1, Li Yang1, Zhi Zheng Ge1.   

Abstract

Collagen triple helix repeat containing 1 (Cthrc1) is a secreted protein that has been observed to lead to poorer prognosis by inducing the invasion and metastasis in different tumors; however, it has not been demonstrated that Cthrc1 is involved in tumor angiogenesis. Immunohistochemical staining of Cthrc1 and CD31 in gastrointestinal stromal tumor tissue demonstrated that Cthrc1 is associated with microvascular density. Overexpression of Cthrc1 protein may alter the properties of human umbilical vein endothelial cells (HUVECs), including migration, invasion, tubule formation and aortic ring sprouting. Small interfering RNA-mediated knockdown of Cthrc1 was performed to verify the opposite effects. Migration and tubule formation induced by Cthrc1 overexpression in HUVECs was attenuated by inhibition of phosphorylation in extracellular-signal-regulated protein kinase (ERK) and c-Jun N-terminal kinase (JNK) signaling pathways. The pro-angiogenic effect of Cthcr1 is associated with increased phosphorylation of ERK and JNK in HUVECs. Silencing the expression of Cthrc1 protein may be a promising strategy to inhibit tumor angiogenesis.

Entities:  

Keywords:  angiogenesis; c-Jun N-terminal kinase; collagen triple helix repeat containing 1; extracellular-signal-regulated kinases; human umbilical vein endothelial cells

Year:  2017        PMID: 29344195      PMCID: PMC5755008          DOI: 10.3892/ol.2017.7111

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration.

Authors:  Peter Pyagay; Mélanie Heroult; Qiaozeng Wang; Wolfgang Lehnert; John Belden; Lucy Liaw; Robert E Friesel; Volkhard Lindner
Journal:  Circ Res       Date:  2004-12-23       Impact factor: 17.367

2.  Cthrc1 selectively activates the planar cell polarity pathway of Wnt signaling by stabilizing the Wnt-receptor complex.

Authors:  Shinji Yamamoto; Osamu Nishimura; Kazuyo Misaki; Michiru Nishita; Yasuhiro Minami; Shigenobu Yonemura; Hiroshi Tarui; Hiroshi Sasaki
Journal:  Dev Cell       Date:  2008-07       Impact factor: 12.270

Review 3.  Tumor angiogenesis: therapeutic implications.

Authors:  J Folkman
Journal:  N Engl J Med       Date:  1971-11-18       Impact factor: 91.245

Review 4.  Fibroblasts in cancer.

Authors:  Raghu Kalluri; Michael Zeisberg
Journal:  Nat Rev Cancer       Date:  2006-05       Impact factor: 60.716

5.  MMP-9-hemopexin domain hampers adhesion and migration of colorectal cancer cells.

Authors:  M Burg-Roderfeld; M Roderfeld; S Wagner; C Henkel; J Grötzinger; E Roeb
Journal:  Int J Oncol       Date:  2007-04       Impact factor: 5.650

Review 6.  A cytokine-mediated link between innate immunity, inflammation, and cancer.

Authors:  Wan-Wan Lin; Michael Karin
Journal:  J Clin Invest       Date:  2007-05       Impact factor: 14.808

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  A role for planar cell polarity signaling in angiogenesis.

Authors:  Pasquale Cirone; Shengda Lin; Hilary L Griesbach; Yi Zhang; Diane C Slusarski; Craig M Crews
Journal:  Angiogenesis       Date:  2008-09-17       Impact factor: 9.596

9.  Treatment of cholestatic fibrosis by altering gene expression of Cthrc1: Implications for autoimmune and non-autoimmune liver disease.

Authors:  Zhaolian Bian; Qi Miao; Wei Zhong; Haiyan Zhang; Qixia Wang; Yanshen Peng; Xiaoyu Chen; Canjie Guo; Li Shen; Fan Yang; Jie Xu; Dekai Qiu; Jingyuan Fang; Scott Friedman; Ruqi Tang; M Eric Gershwin; Xiong Ma
Journal:  J Autoimmun       Date:  2015-08-01       Impact factor: 7.094

10.  Overexpression of collagen triple helix repeat containing 1 (CTHRC1) is associated with tumour aggressiveness and poor prognosis in human non-small cell lung cancer.

Authors:  Zunfu Ke; Weiling He; Yuanhui Lai; Xuefeng Guo; Sharon Chen; Shuhua Li; Yuefeng Wang; Liantang Wang
Journal:  Oncotarget       Date:  2014-10-15
View more
  4 in total

1.  Prolyl 4-hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls.

Authors:  Johanna Eriksson; Vadim Le Joncour; Tiina Jahkola; Susanna Juteau; Pirjo Laakkonen; Olli Saksela; Erkki Hölttä
Journal:  Mol Oncol       Date:  2020-02-28       Impact factor: 6.603

2.  Collagen triple helix repeat containing-1 promotes functional recovery of sweat glands by inducing adjacent microvascular network reconstruction in vivo.

Authors:  Xingyu Yuan; Xianlan Duan; Zhao Li; Bin Yao; Wei Song; Yi Kong; Yuzhen Wang; Fanliang Zhang; Liting Liang; Shijun Zhu; Mengde Zhang; Chao Zhang; Sha Huang; Xiaobing Fu
Journal:  Burns Trauma       Date:  2022-08-02

Review 3.  The Role of CTHRC1 in Regulation of Multiple Signaling and Tumor Progression and Metastasis.

Authors:  Dan Mei; Yue Zhu; Lingling Zhang; Wei Wei
Journal:  Mediators Inflamm       Date:  2020-08-12       Impact factor: 4.711

4.  High CTHRC1 expression may be closely associated with angiogenesis and indicates poor prognosis in lung adenocarcinoma patients.

Authors:  Yangshan Chen; Yu Sun; Yongmei Cui; Yiyan Lei; Neng Jiang; Wenting Jiang; Han Wang; Lili Chen; Jiping Luo; Yanyang Chen; Kejing Tang; Chengzhi Zhou; Zunfu Ke
Journal:  Cancer Cell Int       Date:  2019-11-29       Impact factor: 5.722

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.